tiprankstipranks
Medavail postpones reporting Q4, FY22 results
The Fly

Medavail postpones reporting Q4, FY22 results

MedAvail Holdings is postponing its scheduled earnings release and conference call for the fourth quarter and full-year ended December 31, 2022 previously scheduled for today. The Company requires additional time to complete the preparation and corresponding audit of its consolidated condensed financial statements as of and for the year ended December 31, 2022. In connection with the Company’s divestiture of its pharmacy services business, the Company and its auditors need more time to complete their year-end procedures and reporting. The Company plans to file a timely Notification Late Filing on Form 12b-25 to extend the filing deadline for the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022. The Company will announce the date and time of its scheduled fourth quarter and full-year ended December 31, 2022 financial results and conference call in a future press release.

Published first on TheFly

See today’s best-performing stocks on TipRanks >>

Read More on MDVL:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles